Автор: Matthew R. Kriss

Legislative mandates and incentives, volatility in oil prices and new research and technological advances are driving the expectation of major increases in the production of biofuels from cellulosic …

Tamoxifen was first approved in 1977 and up to now remains a noteworthy therapeutic weapon to treat mainly breast cancer. However, further considerations exist regarding the tamoxifen profile. This b …